We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 14

Statutory sickness insurance fund governed by procurement law

  • Nabarro LLP
  • -
  • European Union, Germany
  • -
  • July 13 2009

On 11 June 2009, the European Court of Justice (ECJ) ruled that a German statutory sickness fund (the Fund) would fall within the definition of a "body governed by public law" under the procurement rules

Italian concession for management consulting services for pharmacies

  • Nabarro LLP
  • -
  • European Union, Italy
  • -
  • April 8 2009

In 1998 and 2002, two Italian communes entered into service concessions for the supply of management consulting services to pharmacies in their local areas without any form of competitive tender

Rules on pharmacy opening times not anti-competitive advises Advocate-General

  • Nabarro LLP
  • -
  • European Union
  • -
  • March 22 2010

Advocate General Jaaskinen's Op supports Member States' right to maintain regional laws restricting pharmacy opening hours

Pfizer’s acquisition of Wyeth given conditional green light

  • Nabarro LLP
  • -
  • European Union
  • -
  • August 6 2009

The US global pharmaceutical company Pfizer has been given conditional approval by the European Commission (Commission) to acquire Wyeth, a US rival

Pharmaceutical company Lundbeck under competition investigation

  • Nabarro LLP
  • -
  • European Union
  • -
  • January 13 2010

On 7 January 2010, the European Commission announced a formal investigation into alleged breaches of Articles 101 & 102 TFEU (formerly Articles 81 & 82 EC) by Lundbeck, a pharmaceutical company

Patent settlement agreements come under Commission scrutiny

  • Nabarro LLP
  • -
  • European Union
  • -
  • January 28 2010

Hot on the heels of the pharmaceutical sector inquiry in 2009 and the formal proceedings opened against Lundbeck, the European Commission revealed that it sent requests to a number of large pharmaceutical companies for copies of recent patent settlement agreements

French pharmaceutical group accused of providing misleading information during the ‘phama inquiry’

  • Nabarro LLP
  • -
  • European Union
  • -
  • August 9 2010

The European Commission claims it has evidence that a French pharmaceutical group, Servier, provided misleading and incorrect information in the context of the pharmaceutical sector competition inquiry in 2008

General Court dismisses appeal against dawn raid of French pharmacy associations

  • Nabarro LLP
  • -
  • European Union, France
  • -
  • November 16 2010

The General Court has dismissed an appeal by two French Pharmacy associations (the 'CONP' and the 'CCG') against a decision by the European Commission ordering them to submit to an unannounced competition inspection

Commission asks ECJ to fine Greece for failure to comply with its judgment on medical equipment

  • Nabarro LLP
  • -
  • European Union, Greece
  • -
  • November 29 2010

On 19 March 2009, the European Court of Justice (ECJ) ruled that Greece had breached EU law by rejecting offers from suppliers of medical equipment bearing the 'CE' mark

Astrazeneca patent misuse case largely upheld

  • Nabarro LLP
  • -
  • European Union
  • -
  • July 16 2010

On 1 July 2010, the General Court upheld the majority of the Commission's 2005 decision to fine pharmaceutical company, AstraZeneca, for abuses of a dominant position